Ilika collaborates with Cirtec Medical to advance solid-state battery technology

Ilika plc, a renowned innovator in solid-state battery technology, has finalized its contractual negotiations with Cirtec Medical. Cirtec Medical is a prominent strategic outsourcing partner specializing in the development of complex medical devices, particularly minimally invasive devices. Building on their previous announcement in January 2023, the collaboration aims to revolutionize the integration of solid-state batteries into medical devices.

Solid-state batteries have garnered interest in the industry due to their potential to provide higher energy densities, increased safety, and longer lifetimes compared to conventional batteries. These innovative batteries are particularly appealing for medical devices as they contribute to enhanced performance and reliability, crucial factors in the healthcare field.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Ilika plc

More articles like this

Ilika plc

Effective power management for rechargeable batteries

As rechargeable batteries become increasingly integrated into our daily lives, ensuring they charge, store, and discharge energy efficiently and safely throughout their operational lifetime is crucial. Typically, this is achieved through a stand-alone Power Management Integrated

Ilika plc

Ilika’s journey from 2015-2019

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Ilika plc

Ilika celebrates 20 years of innovation and growth

Ilika Technologies has reached its 20th anniversary. Originally focused on high-throughput materials discovery, the company was founded by CEO Graeme Purdy to commercialise technology from the University of Southampton’s Department of Chemistry. The early years, led

Ilika plc

Ilika provides comprehensive update on FY24 trading

Ilika’s unaudited trading results for the year ended 30 April 2024 have aligned with management expectations. The Company anticipates reporting revenues of approximately £2.1 million (2023: £0.7 million), with an EBITDA loss excluding share-based payments of